-
-
-
-
-
-
-
Cantor Still Likes Valeant Pharma (VRX) Despite The CRL
-
-
-
-
-
-
-
Valeant Pharma (VRX) to Change Name to Bausch Health (BHC) - WSJ
-
-
-
-
-
-
-
Valeant Pharmaceuticals (VRX) PT Raised to $18 at Canaccord Genuity
-
-
-
-
-
-
-
Cantor Fitzgerald Is Positive On Valeant Pharma (VRX), Reiterates Overweight and $23 Price Target
-
-
-
-
-
-
-
Valeant Will Release Third-Quarter 2017 Financial Results On November 7
-
-
-
-
-
-
-
Mizuho Cautious Into Valeant Pharmaceuticals (VRX) Q2 Print
-
-
-
-
-
-
-
Valeant Pharma (VRX) Completes Sale Of Dendreon to Sanpower Group, Reiterates Expectation to Pay Down $5B in Debt
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

